The study found that the abnormal expression of BRD4 is related to glioma, and the expression in glioma is significantly higher than that in normal tissue (130); BRD4 inhibitors effectively penetrated the blood-brain barrier and targeted glioma tumor tissue, but had little effect on normal brain tissue (130). This evidence concerns the gene BRD4 and glioma.